Abstract
5-HT1D and 5-HT1E/1F receptor binding sites were measured in brain samples obtained at post-mortem from suicide victims with a firm retrospective diagnosis of depression, and matched controls. In antidepressant-free suicides a significantly higher number of 5-HT1D receptors was found in globus pallidus. This was largely restricted to those suicides who died by violent means. This effect was not observed in antidepressant-treated suicides. No differences or trends in 5-HT1D binding were found in putamen, parietal or frontal cortex, in antidepressant-free or antidepressant-treated suicides. There were no differences in the number of 5-HT1E/1F receptors in any of the regions studied.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lowther, S., Katona, C., Crompton, M. et al. 5-HT1D and 5-HT1E/1F binding sites in depressed suicides: increased 5-HT1D binding in globus pallidus but not cortex. Mol Psychiatry 2, 314–321 (1997). https://doi.org/10.1038/sj.mp.4000259
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000259
Keywords
This article is cited by
-
An overview of the neurobiology of suicidal behaviors as one meta-system
Molecular Psychiatry (2015)
-
Substance Abuse Disorder and Major Depression are Associated with the Human 5-HT1B Receptor Gene (HTR1B) G861C Polymorphism
Neuropsychopharmacology (2003)